NCT00265837
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Clinical trial condition
Lymphoma, B-Cell, Marginal Zone
Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.
646 public trials
88 recruiting studies
Lymphoma, B-Cell, Marginal Zone trial results
NCT00724984
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Northwestern University Medical School Chicago, Illinois, United States
- Horizon Oncology Center Lafayette, Indiana, United States
- University of Massachusetts Medical School Worcester, Massachusetts, United States
NCT01233921
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
NCT00004145
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
- Locations
-
- University of Chicago Cancer Research Center Chicago, Illinois, United States
NCT00538850
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +260 more
- Locations
-
- InSys Therapeutics, Incorporated Chandler, Arizona, United States
NCT00438958
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +61 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
- Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
- Royal Melbourne Hospital Parkville, Victoria, Australia
- Vancouver Hospital and Health Science Center Vancouver, British Columbia, Canada
NCT00499811
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- National Institutes of Health Bethesda, Maryland, United States
NCT00458731
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +116 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00769288
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
- Locations
-
- Wayne State University Detroit, Michigan, United States